back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-11-11 12:14 Tx date 2024-11-08 |
$VPH
VALEO PHARMA INC. |
Dumais, Frédéric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2024-11-11 12:13 Tx date 2024-11-08 |
$VPH
VALEO PHARMA INC. |
Dumais, Frédéric
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12.00% Conv ($1.15) Dec 31 2024
00 - Opening Balance-Initial SEDI Report
|
$45,000 | ||
| Filed 2024-11-11 12:12 Tx date 2024-11-08 |
$VPH
VALEO PHARMA INC. |
Dumais, Frédéric
5 - Senior Officer of Issuer
Holder: 9393-0907 Quebec Inc (Indirect Ownership)
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
41,000 | ||
| Filed 2024-11-11 12:11 Tx date 2024-11-08 |
$VPH
VALEO PHARMA INC. |
Dumais, Frédéric
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
217,500 | ||
| Filed 2024-04-30 11:55 Tx date 2024-02-19 |
$VPH
VALEO PHARMA INC. |
Allard, Guy Paul
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-222,222 vol |
225,000 | |
| Filed 2024-03-25 09:26 Tx date 2024-03-21 |
$VPH
VALEO PHARMA INC. |
Moghaddam, Ali Ghaderi
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-14 15:10 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
$2,271
+8,572 vol $0.265 each |
21,965 | |
| Filed 2024-02-14 15:08 Tx date 2024-02-14 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-3,549.145
-13,393 vol $0.265 each |
0 | |
| Filed 2024-02-13 17:20 Tx date 2024-02-12 |
$VPH
VALEO PHARMA INC. |
Bisaillon, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-29 13:01 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+13,393 vol |
13,393 | |
| Filed 2023-11-29 13:00 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Komari, Nelly
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,393 vol |
13,393 | |
| Filed 2023-11-29 12:57 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
57 - Exercise of rights
|
+19,394 vol |
19,394 | |
| Filed 2023-11-29 12:56 Tx date 2022-08-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-29 12:56 Tx date 2023-11-29 |
$VPH
VALEO PHARMA INC. |
Steiger, Kyle
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,303 vol |
0 | |
| Filed 2023-11-22 09:50 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2023-11-22 09:48 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-22 09:47 Tx date 2023-11-20 |
$VPH
VALEO PHARMA INC. |
Tougas, Pascal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-09 12:22 Tx date 2023-11-01 |
$VPH
VALEO PHARMA INC. |
Lajoie, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-28 17:53 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Saviuk, Steve
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Manitex Capital Inc. (Control or Direction)
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
23,322,987 | |
| Filed 2023-09-28 10:40 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
2,648,055 |